ESR1 and triple-negative breast carcinoma: Notably, a recent study reported that FKBP4 potentiated AKT signaling to facilitate the proliferation and survival of triple-negative breast cancer cells, suggesting that the regulatory mechanism is independent of ER, at least in these ER-negative models22.